Consolidated Statement Of Income

Cyfuse Biomedical K.K. - Filing #7311816

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Consolidated statement of income
Statement of income
Net sales
18,042,000 JPY
18,272,000 JPY
Operating expenses
Selling, general and administrative expenses
456,294,000 JPY
373,237,000 JPY
Cost of sales
10,712,000 JPY
8,691,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
57,450,000 JPY
57,937,000 JPY
Rent expenses on land and buildings
12,808,000 JPY
12,519,000 JPY
Operating expenses
Operating profit (loss)
-448,964,000 JPY
-363,656,000 JPY
Ordinary profit (loss)
-445,993,000 JPY
-362,953,000 JPY
Gross profit (loss)
7,330,000 JPY
9,580,000 JPY
Net sales
General and administrative expenses
Salaries
Operating expenses
Research and development expenses
231,804,000 JPY
182,566,000 JPY
Cost of sales
Non-operating income
Interest income
30,000 JPY
18,000 JPY
Other
185,000 JPY
527,000 JPY
Non-operating income
12,936,000 JPY
11,060,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Interest expenses
4,494,000 JPY
4,987,000 JPY
Non-operating expenses
9,965,000 JPY
10,358,000 JPY
Profit (loss) before income taxes
-445,993,000 JPY
-362,953,000 JPY
Gross profit
Income taxes - current
1,220,000 JPY
1,652,000 JPY
Income taxes
1,220,000 JPY
1,652,000 JPY
Profit (loss)
-447,213,000 JPY
-364,606,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.